Relay Therapeutics, Inc. RLAY Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s change in AP?
- Relay Therapeutics, Inc. (RLAY) reported change in AP of $3.67M in Q1 2026.
- How has Relay Therapeutics, Inc.'s change in AP changed year-over-year?
- Relay Therapeutics, Inc.'s change in AP increased by 206.4% year-over-year, from -$3.45M to $3.67M.
- What is the long-term trend for Relay Therapeutics, Inc.'s change in AP?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s change in AP has grown at a 87.3% compound annual growth rate (CAGR), from $930K to -$11.44M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.